📊 FUNI Key Takeaways
Is FUNI a Good Investment? Thesis Analysis
Hypha Labs exhibits severe financial distress with negative stockholders' equity of -2.7M, indicating the company is technically insolvent. Despite a dramatic 4,180% revenue increase, profitability has deteriorated significantly with operating and net margins of -65.4% and -71.8% respectively, while negative free cash flow of -183.2K demonstrates the company cannot sustain operations from core business activities.
Why Buy FUNI? Key Strengths
- Exceptional year-over-year revenue growth of 4,179.7% suggesting strong market demand
- Gross margin of 41.8% indicates reasonable unit economics at the product level
- Company maintains minimal cash position of 42.9K despite operational challenges
FUNI Investment Risks to Consider
- Negative stockholders' equity of -2.7M represents technical insolvency and bankruptcy risk
- Operating cash flow of -150.2K and free cash flow of -183.2K indicate unsustainable burn rate
- Current ratio of 0.24x and quick ratio of 0.21x signal severe liquidity crisis with liabilities 6.9x total assets
- Net loss of -521.6K on only 726.8K revenue demonstrates inability to scale profitably
- Long-term debt of 1.3M against negative equity creates existential debt service risk
- Interest coverage ratio of -3.0x indicates inability to service debt obligations from operations
Key Metrics to Watch
- Path to operating cash flow positivity and timeline to break-even operations
- Quarterly burn rate trend and runway before insolvency
- Changes in liabilities and debt restructuring or refinancing activities
- Revenue quality and sustainability of growth given operational losses
- Management execution on cost structure to achieve profitability at current revenue levels
FUNI Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
FUNI Profitability Ratios
FUNI vs Default Sector
How Hypha Labs, Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is FUNI Overvalued or Undervalued?
Based on fundamental analysis, Hypha Labs, Inc. has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
FUNI Balance Sheet & Liquidity
FUNI 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Hypha Labs, Inc.'s revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
FUNI Growth Metrics (YoY)
FUNI Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2023 | $699.6K | -$240.3K | $0.00 |
| Q3 2022 | $682.7K | $18.2K | $0.00 |
| Q2 2022 | $604.7K | $18.2K | $0.00 |
| Q1 2022 | $500.4K | -$290.3K | N/A |
| Q3 2021 | $407.2K | -$177.2K | N/A |
| Q2 2021 | $633.2K | $18.2K | $0.00 |
| Q1 2021 | $500.4K | -$220.4K | N/A |
| Q3 2020 | $407.2K | -$489.6K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
FUNI Capital Allocation
FUNI SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Hypha Labs, Inc. (CIK: 0001502966)
📋 Recent SEC Filings
❓ Frequently Asked Questions about FUNI
What is the AI rating for FUNI?
Hypha Labs, Inc. (FUNI) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are FUNI's key strengths?
Claude: Exceptional year-over-year revenue growth of 4,179.7% suggesting strong market demand. Gross margin of 41.8% indicates reasonable unit economics at the product level.
What are the risks of investing in FUNI?
Claude: Negative stockholders' equity of -2.7M represents technical insolvency and bankruptcy risk. Operating cash flow of -150.2K and free cash flow of -183.2K indicate unsustainable burn rate.
What is FUNI's revenue and growth?
Hypha Labs, Inc. reported revenue of $726.8K.
Does FUNI pay dividends?
Hypha Labs, Inc. does not currently pay dividends.
Where can I find FUNI SEC filings?
Official SEC filings for Hypha Labs, Inc. (CIK: 0001502966) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is FUNI's EPS?
Hypha Labs, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is FUNI a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, Hypha Labs, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is FUNI stock overvalued or undervalued?
Valuation metrics for FUNI: ROE of N/A (sector avg: 15%), net margin of -71.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy FUNI stock in 2026?
Our dual AI analysis gives Hypha Labs, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is FUNI's free cash flow?
Hypha Labs, Inc.'s operating cash flow is $-150.2K, with capital expenditures of $33.0K. FCF margin is -25.2%.
How does FUNI compare to other Default stocks?
Vs Default sector averages: Net margin -71.8% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.24 (avg: 1.8).